Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
EMIM 2023: European Molecular Imaging Meeting
It’s Salzburg and we could not be more excited…
About the meeting:
EMIM 2023 will be a full in-person event, with no virtual/hybrid options foreseen. Come see us at Booth 315 to discuss how we can provide you with preclinical research solutions!
When does the meeting take place?
Date: 14-17 March 2023
Venue: Salzburg Congress
Salzburg, Austria
Science Fun Facts:
It was in Salzburg that Albert Einstein is said to have presented his theory of relativity for the first time. On 21 September 1909 he presented his work at the “Forschungstage” in the gym of the Andräschule in the city of Salzburg. It was the first congress he visited.
Did you know that Christian Doppler was born in Salzburg on 29 November 1803? It was him who said that “The most rewarding researches are those which, by pleasing the thinker, are at the same time useful to mankind”.
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders